Stem cell transplantation for Hodgkin's disease: A review of the literature

Research output: Contribution to journalArticlepeer-review


High-dose chemotherapy followed by autologous peripheral-blood stem cell transplantation has resulted in long-term disease-free survival of 30%-60% in selected patients with refractory and relapsed Hodgkin's disease. In addition, a significant reduction in early transplant-related mortality in more recent studies has led to the widespread acceptance of autografting. Comparatively few studies of allografting for Hodgkin's disease have been performed. Although no prospective randomized trials have been performed, historical results show a significantly lower relapse rate when allografting results are compared to autografting results. These results suggest that a graft-versus-Hodgkin's disease effect may exist. Unfortunately, the lower relapse rate following allografting is offset by higher transplant-related mortality. The use of low-intensity nonmyeloablative regimens for allografting may harness a graft-versus-Hodgkin's disease effect with less morbidity and mortality than that observed following conventional allografting.

Original languageEnglish
Pages (from-to)212-221
Number of pages10
JournalClinical Lymphoma
Issue number4
Publication statusPublished - 2002


  • Allogeneic transplants
  • Autologous stem cell transplantation
  • Hodgkin's disease
  • Relapsed disease

ASJC Scopus subject areas

  • Cancer Research


Dive into the research topics of 'Stem cell transplantation for Hodgkin's disease: A review of the literature'. Together they form a unique fingerprint.

Cite this